Page last updated: 2024-09-04

carbapenems and Anorectal Diseases

carbapenems has been researched along with Anorectal Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Z; Kang, M; Li, M; Liu, M; Song, Q; Wu, L; Xie, Y; Zhao, D1

Other Studies

1 other study(ies) available for carbapenems and Anorectal Diseases

ArticleYear
Extended-spectrum β-lactamase-producing E. coli septicemia among rectal carriers in the ICU.
    Medicine, 2018, Volume: 97, Issue:38

    Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Carrier State; Case-Control Studies; Cephalosporins; China; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Hospital Mortality; Hospitals; Humans; Intensive Care Units; Male; Middle Aged; Rectal Diseases; Retrospective Studies; Risk Factors

2018